TABLE 2.
Knowledge questions |
Total n = 248 (%) |
Chawama n = 64 (%) |
Chilenje n = 35 (%) |
Chipata n = 25 (%) |
Kanyama n = 71 (%) |
Matero n = 53 (%) |
p‐Value a |
---|---|---|---|---|---|---|---|
The possible causative agent for cervical cancer | 111 (44.8) | 12 (34.3) | 29 (45.3) | 16 (30.2) | 7 (28.00) | 47 (66.2) | <.001 |
Having multiple sexual partners is a risk factor for cervical cancer | 110 (45.5) | 17 (53.1) | 30 (46.9) | 17 (33.3) | 10 (40.0) | 36 (51.4) | .273 |
Infection by HPV is a risk of cervical cancer | 182 (73.4) | 24 (68.6) | 53 (82.8) | 39 (73.6) | 19 (76.0) | 47 (66.2) | .258 |
Vaginal discharge is a symptom for cervical cancer | 103 (41.7) | 11 (31.4) | 31 (48.4) | 12 (23.1) | 10 (40.0) | 39 (54.9) | .004 |
Vaginal bleeding is a symptom for cervical cancer | 132 (53.2) | 17 (48.6) | 36 (56.3) | 23 (43.4) | 13 (52.0) | 43 (60.6) | .386 |
Cervical cancer is preventable | 143 (57.7) | 20 (57.1) | 37 (57.8) | 26 (49.1) | 17 (68.0) | 43 (60.6) | .566 |
Vaccination with HPV vaccine prevents cervical cancer | 151 (60.9) | 21 (60.0) | 39 (60.9) | 28 (52.8) | 18 (72.0) | 45 (63.4) | .568 |
Screening can detect cervical cancer early | 160 (64.5) | 21 (60.0) | 44 (68.6) | 30 (56.6) | 21 (84.0) | 44 (61.9) | .158 |
Cervical cancer screening for HIV‐positive women is at any age | 171 (68.9) | 24 (68.6) | 44 (68.8) | 35 (66.0) | 19 (76.0) | 49 (69.0) | .939 |
Overall score, mean (SD) | 6.86 (2.76) | 6.40 (2.76) | 7.17 (2.68) | 6.28 (2.47) | 7.72 (1.74) | 6.92 (3.26) | .161 b |
Abbreviation: SD, standard deviation.
p‐values from Pearson chi‐square test or Fisher's exact test as appropriate.
One‐way analysis of variance (ANOVA).